These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2049484)

  • 1. Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients.
    Newcomer JW; Faustman WO; Whiteford HA; Moses JA; Csernansky JG
    Biol Psychiatry; 1991 May; 29(9):855-64. PubMed ID: 2049484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment and cortisol levels in first-episode schizophrenia patients.
    Havelka D; Prikrylova-Kucerova H; Prikryl R; Ceskova E
    Stress; 2016 Jul; 19(4):383-9. PubMed ID: 27320489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression, negative and positive symptoms, and the DST in schizophrenia.
    Minas IH; Jackson HJ; Joshua SD; Burgess PM
    Schizophr Res; 1990; 3(5-6):321-7. PubMed ID: 2282337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test and negative symptoms of schizophrenia.
    McGauley GA; Aldridge CR; Fahy TA; Eastment C
    Acta Psychiatr Scand; 1989 Dec; 80(6):548-53. PubMed ID: 2618777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome.
    Tandon R; Mazzara C; DeQuardo J; Craig KA; Meador-Woodruff JH; Goldman R; Greden JF
    Biol Psychiatry; 1991 May; 29(10):953-64. PubMed ID: 1676605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luria-Nebraska performance and symptomatology in unmedicated schizophrenic patients.
    Faustman WO; Moses JA; Csernansky JG
    Psychiatry Res; 1988 Oct; 26(1):29-34. PubMed ID: 3237904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive and negative symptoms in schizophrenia and the Dexamethasone Suppression Test.
    Tandon R; Silk KR; Greden JF; Goodson J; Hariharan M; Meador-Woodruff JH; Kronfol Z
    Biol Psychiatry; 1989 Mar; 25(6):788-92. PubMed ID: 2629711
    [No Abstract]   [Full Text] [Related]  

  • 9. DST and schizophrenic symptomatology.
    Keshavan MS; Brar J; Ganguli R; Jarrett D
    Biol Psychiatry; 1989 Dec; 26(8):856-8. PubMed ID: 2590699
    [No Abstract]   [Full Text] [Related]  

  • 10. Negative symptoms of schizophrenia and the dexamethasone suppression test.
    Garyfallos G; Lavrentiadis G; Amoutzias D; Monas K; Manos N
    Acta Psychiatr Scand; 1993 Dec; 88(6):425-8. PubMed ID: 8310850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone nonsuppression in chronic schizophrenia.
    Whiteford HA; Riney SJ; Savala RA; Csernansky JG
    Acta Psychiatr Scand; 1988 Jan; 77(1):58-62. PubMed ID: 3273153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between dexamethasone nonsuppression and negative symptoms in schizophrenic patients.
    Tandon R
    Acta Psychiatr Scand; 1989 Nov; 80(5):524-5. PubMed ID: 2574530
    [No Abstract]   [Full Text] [Related]  

  • 13. Dexamethasone suppression test, schizophrenia and movement disorder.
    Aleem A; Kulkarni A; Yeragani VK
    Acta Psychiatr Scand; 1988 Dec; 78(6):689-94. PubMed ID: 3223326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF 5-HIAA, serum cortisol, and age differentially predict vegetative and cognitive symptoms in depression.
    Faustman WO; Faull KF; Whiteford HA; Borchert C; Csernansky JG
    Biol Psychiatry; 1990 Feb; 27(3):311-8. PubMed ID: 1689187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia.
    Cuesta MJ; Peralta V
    Psychiatry Res; 1995 Oct; 58(3):227-35. PubMed ID: 8570778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional significance of symptomatology and cognitive function in schizophrenia.
    Velligan DI; Mahurin RK; Diamond PL; Hazleton BC; Eckert SL; Miller AL
    Schizophr Res; 1997 May; 25(1):21-31. PubMed ID: 9176924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment and negative symptoms in geriatric chronic schizophrenic patients: a follow-up study.
    Harvey PD; Lombardi J; Leibman M; White L; Parrella M; Powchik P; Davidson M
    Schizophr Res; 1996 Dec; 22(3):223-31. PubMed ID: 9000319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative and depressive symptoms in suicidal schizophrenics.
    Jones JS; Stein DJ; Stanley B; Guido JR; Winchel R; Stanley M
    Acta Psychiatr Scand; 1994 Feb; 89(2):81-7. PubMed ID: 8178667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression test in residual schizophrenia with depression.
    Munro JG; Hardiker TM; Leonard DP
    Am J Psychiatry; 1984 Feb; 141(2):250-2. PubMed ID: 6691488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.